Combined Ruxolitinib and Venetoclax Treatment in a Patient with a BCR-JAK2 Rearranged Myeloid Neoplasm

Hematological malignancies with a BCR-JAK2 rearrangement have been described only sporadically in the literature over the last three decades. Although most patients suffer from a chronic myeloid neoplasm with marked eosinophilia, the clinical presentation varies significantly and can even manifest a...

Descripción completa

Detalles Bibliográficos
Autores principales: Lap, Coen J., Nassereddine, Samah, Liu, Min-Ling, Nava, Victor E., Aggarwal, Anita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8337103/
https://www.ncbi.nlm.nih.gov/pubmed/34367701
http://dx.doi.org/10.1155/2021/2348977

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8337103/
https://www.ncbi.nlm.nih.gov/pubmed/34367701
http://dx.doi.org/10.1155/2021/2348977

Ejemplares similares